Carbon nanotubes towards medicinal biochips

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 1, 2010, Pages 1-10

  Tarakanov, Alexander O ^a   Goncharova, Larisa B ^b   Tarakanov, Yury A ^c  

^a ST PETERSBURG INSTITUTE FOR INFORMATICS AND AUTOMATION   (Russian Federation)

^b City Diagnostic Center Virology   (Russian Federation)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MEDICINE;

BIOASSAY; BIOCHIPS;

CARBON NANOTUBES;

CARBON NANOTUBE; G PROTEIN COUPLED RECEPTOR; NANODISC;

BIOCHIP; BIOSENSOR; DIAGNOSTIC PROCEDURE; DIMERIZATION; DNA MICROARRAY; DRUG SCREENING; GENETIC SCREENING; HUMAN; MEDICINE; MICROARRAY ANALYSIS; NANOBIOTECHNOLOGY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTEIN MICROARRAY; REVIEW; SEMICONDUCTOR;

ANIMALS; BIOMEDICAL TECHNOLOGY; DRUG DELIVERY SYSTEMS; HUMANS; MICROCHIP ANALYTICAL PROCEDURES; NANOTUBES, CARBON;

EID: 77953652461     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.69     Document Type: Review

References (102)

1. Goncharova LB, Tarakanov AO. Nanotubes at neural and immune synapses. Curr Med Chem 2008, 15:210-218.
2. Saito N, Usui Y, Aoki K, Narita N, Shimizu M, et al. Carbon nanotubes for biomaterials in contact with bone. Curr Med Chem 2008, 15:523-527.
3. Tarakanov YA, Kinaret JM. A carbon nanotube field effect transistor with a suspended nanotube gate. Nano Lett 2007, 7:2291-2294.
4. Svensson J, Tarakanov YA, Lee DS, Kinaret JM, Park YW, et al. A carbon nanotube gated carbon nanotube transistor with 5 ps gate delay. Nanotechnology 2008, 19:325201.
5. Huang XJ, Choi YK. Chemical sensors based on nanostructured materials. Sens Actuators, A 2007, 122:659-671.
6. Gruner G. Carbon nanotube transistors for biosensing applications. Anal Bioanal Chem 2006, 384:322-335.
7. Kirgoz UA, Timur S, Odaci D, Perez B, Alegret S, et al. Carbon nanotube composite as novel platform for microbial biosensor. Electroanalysis 2007, 19:893-898.
8. Pumera M, Sánchez S, Ichinose I, Tang J. Electrochemical nanobiosensors. Sens Actuators, A 2007, 123:1195-1205.
9. Pumera M, Merkoçi A, Alegret S. Carbon nanotube detectors for microchip: comparative study of single-wall and multiwall carbon nanotube, and graphite powder films on glassy carbon, gold, and platinum electrode surfaces. Electrophoresis 2007, 28:1274-1280.
10. Scheller FW. From biosensor to biochip. FEBS Lett 2007, 274:5451.
11. Wang YF, Zhang YQ, Jiang XD. The application of nanoparticles in biochips. Recent Pat Biotechnol 2008, 2:55-59.
12. Wong CW, Heng CLW, Yee LW, Soh SWL, Kartasasmita CB, et al. Optimization and clinical validation of a pathogen detection microarray. Genome Biol 2007, 8:R93.
13. Stears RL,Martinsky T, Schena M. Trends in microarray analysis. Nat Med 2003, 9:140-145.
14. Khanna VK. Existing and emerging detection technologies for DNA finger printing, sequencing, bioand analytical chips: a multidisciplinary development unifying molecular biology, chemical and electronics engineering. Biotechnol Adv 2007, 25:85-98.
15. Chen B, Parker G, Han J,MeyyappanM, Cassell AM. Heterogeneous single-walled carbon nanotube catalyst discovery and optimization. Chem Mater 2002, 14:1891-1896.
16. Koehne JE, Chen H, Cassell AM, Ye Q, Han J, et al.Miniaturized multiplex label-free electronic chip for rapid nucleic acid analysis based on carbon nanotube nanoelectrode arrays. Clin Chem 2004, 50:1886-1893.
17. Fortina P, Surrey S, Kricka LJ. Molecular diagnostics: hurdles for clinical implementation. Trends Mol Med 2002, 8:264-266.
18. Borini S, Staiano M, Rocchia M, Rossi AM, Rossi M, et al. Advanced nanotechnological approaches for designing protein-based 'lab-on-chips' sensors on porous silicon wafer. Recent Pat DNA Gene Seq 2007, 1:1-7.
19. Cui HF, Ye JS, Chen Y, Chong SC, Sheu FS. Microelectrode array biochip: tool for in vitro drug screening based on the detection of a drug effect on dopamine release from PC12 cells. Anal Chem 2006, 78:6347-6355.
20. Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, et al. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J Neural Transm 2007, 114:49-75.
21. Fuxe KG, Tarakanov AO, Goncharova LB, Agnati LF. A new road to neuroinflammation in Parkinson's disease? Brain Res Rev 2008, 58:453-458.
22. Goncharova LB, Jacques Y, Martin-Vide C, Tarakanov AO, Timmis JI. Biomolecular immunecomputer: theoretical basis and experimental simulator. Lect Notes Comput Sci 2005, 3627:72-85.
23. Gabig-Ciminska M. Developing nucleic acid-based electrical detection systems. Microb Cell Fact 2006, 5:9-16.
24. Gabid M,Wegrzyn G. An introduction to DNA chips: principles, technology, applications and analysis. Acta Biochim Pol 2001, 48:615-622.
25. Gupalova T, Orlova S, Palagnuk V, Volchek N, KusminaM, et al. Usage of recombinant receptor proteins in clinical diagnosis. Folia Vet 1997, 41:81-83.
26. Ramsey M. DNA chips: state-of-the-art. Nat Biotechnol 1998, 16:40-44.
27. Wang J. Nanoparticle-based electrochemical DNA detection. Anal Chim Acta 2003, 500:247-257.
28. Lee YEK, Kopelman R. Optical nanoparticle sensors for quantitative intracellular imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:98-110.
29. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. The sequence of the human genome. Science 2001, 291:1304-1351.
30. Bernard A, Michel B, Delamarche E. Microsaic immunoassays. Anal Chem 2001, 73:8-12.
31. Katzman S. Chip-based mosaic immunoassays. Anal Chem 2001, 73:14A.
32. Thevenot DR, Toth K, Durst RA, Wilson GS. Electrochemical biosensors: recommended definitions and classification. Biosens Bioelectron 2001, 16:121-131.
33. Schöning MJ, Poghossian A. Recent advances in biologically sensitive field-effect transistors (BioFETs). Analyst 2002, 127:1137-1151.
34. Vestergaard M, Kerman K, Tamiya E. An overview of label-free electrochemical protein sensors. Sensors 2007, 7:3442-3458.
35. Maehashi K, Katsura T, Kerman K, Takamura Y, Matsumoto K, et al. Label-free protein biosensor based on aptamer-modified carbon nanotube fieldeffect transistors. Anal Chem 2007, 79:782-787.
36. O'Sullivan CK. Aptasensors-the future of biosensing? Anal Bioanal Chem 2002, 372:44-48.
37. Wang D, Urisman A, Liu YT, Springer M, Ksiazek TG, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 2003, 1:257-260.
38. Rey DA, Batt CA, Miller JC. Carbon nanotubes in biomedical applications. Nanotech Law Business 2006, 3:263-292.
39. Bottini M, Fabio C, Tautz L, Rosato N, Bergamaschi A, et al. Adsorption of streptavidin onto single-walled carbon nanotubes: application in fluorescent supramolecular nanoassemblies. J Nanosci Nanotechnol 2006, 6:3693-3698.
40. Williams KA, Veenhuizen PTM, de la Torre B, Eritja R, Dekker C. Carbon nanotubes with DNA recognition. Nature 2002, 420:761.
41. Lee JO, Wiertz FGM, Heering HA, Dekker C. Enzyme-coated carbon nanotubes as single-molecule biosensors. Nano Lett 2003, 3:727-730.
42. Heller I, Janssens AM, Mannik J, Minot ED, Lemay SG, et al. Identifying the mechanism of biosensing with carbon nanotube transistors. Nano Lett 2008, 8:591-595.
43. Freitag M, Tsang JC, Bol A, Yuan D, Liu J, et al. Imaging of the Schottky barriers and charge depletion in carbon nanotube transistors. Nano Lett 2007, 7:2037-2042.
44. Rowe-Taitt CA, Golden JP, Feldstein MJ, Cras JJ, Hoffman KE, et al. Array biosensor for detection of biohazards. Biosens Bioelectron 2000, 14:785-794.
45. Tsai HC, Doong RA. Simultaneous determination of pH, urea, acetylcholine and heavy metals using array-based enzymatic optical biosensor. Biosens Bioelectron 2005, 20:1796-1804.
46. Moreno-Bondi MC, Taitt CR, Shriver-Lake LC, Ligler FS. Multiplexed measurement of serum antibodies using an array biosensor. Biosens Bioelectron 2006, 21:1880-1886.
47. Liu Q, Bai Y, Ge Q, Zhou S, Wen T, et al. Microarrayin-a-tube for detection of multiple viruses. Clin Chem 2007, 53:188-194.
48. Goncharova LB, Tarakanov AO. Molecular networks of brain and immunity. Brain Res Rev 2007, 55:155-166.
49. Agnati LF, Fuxe KG, Goncharova LB, Tarakanov AO. Receptor mosaics of neural and immune communication: possible implication for basal ganglia functions. Brain Res Rev 2008, 58:400-414.
50. Jain KK. Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta 2005, 358:37-54.
51. Jain KK. The role of nanobiotechnology in drug discovery. Drug Discov Today 2005, 10:1435-1442.
52. Lee TMH, Hsing IM. DNA-based bioanalytical microsystems for handheld device applications. Anal Chim Acta 2006, 556:26-37.
53. Newman J, Turner APF. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron 2005, 20:2435-2453.
54. Zhao Q, Gan Z, Zhuang Q. Electrochemical sensors based on carbon nanotubes. Electroanalysis 2002, 14:1609-1613.
55. Kerman K,NagataniN, ChikaeM, Yuhi T, Takamura Y, et al. Label-free electrochemical immunoassay for the detection of human chorionic gonadotropin hormone. Anal Chem 2006, 78:5612-5616.
56. Sánchez S, Pumera M, Cabruja E, Fábregas E. Carbon nanotube/polysulfone composite screen-printed electrochemical enzyme biosensors. Analyst 2007, 132:142.
57. Greenough A, Alexander J, Burgess S, Bytham J, Chetcuti PAJ, et al. Health care utilization of premature born, preschool children related to hospitalization for RSV infection. Arch Dis Child 2004, 89:673-678.
58. Vestergaard M, Tamiya E. A rapid sample pretreatment protocol: improved sensitivity in the detection of a low-abundant serum biomarker for prostate cancer. Anal Sci 2007, 23:1-4.
59. Beaucage SL. Strategies in the preparation of DNA oligonucleotide arrays for diagnostic applications. Curr Med Chem 2001, 8:1213-1244.
60. Yacoub-George E, Hell W, Meixner L, Wenninger F, Bock K, et al. Automated 10-channel capillary chip immunodetector for biological agents detection. Biosens Bioelectron 2007, 22:1368-1375.
61. Wu W, Zhu H, Fan L, Liu D, Rennenberg R, et al. Sensitive dopamine recognition by boronic acid functionalized multi-walled carbon nanotubes. Chem Commun 2007, 23:2345-2347.
62. Swamy BEK, Venton BJ. Carbon nanotubemodified microelectrodes for simultaneous detection of dopamine and serotonin in vivo. Analyst 2007, 132:876-884.
63. Vestergaard M, Kerman K, Tamiya E. The study of Alzheimer's disease biomarkers: current role and future prospects of nanosensor technology. NanoBiotechnology 2006, 2:5-16.
64. Vestergaard M, Hamada T, Takagi M. Using model membranes for the study of amyloid beta: lipid interactions and neurotoxicity. Biotechnol Bioeng 2008, 99:753-763.
65. Zhang Y, DeVries ME, Skolnick J. Structure modeling of all identified G protein-coupled receptors in the human genome. PLoS Comput Biol 2006, 2:88-99.
66. Uings IJ, Farrow SN. Cell receptors and cell signalling. J Clin Pathol: Mol Pathol 2000, 53:295-299.
67. Takeda S, Kadowaki S, Haga T, Takaesu H, Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 2002, 520:97-101.
68. Prinster SC,Hague C,Hall RA. Heterodimerization of Gprotein-coupled receptors: specificity and functional significance. Pharmacol Rev 2005, 57:289-298.
69. Collins FS. Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
70. Premont RT, Gainetdinov RR. Physiologocal roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 2007, 69:511-534.
71. Pierce KL, Premont RT, Lefkowitz RJ. Seventransmembrane receptors. Nat Rev Mol Cell Biol 2002, 3:639-650.
72. Flower DR. Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1999, 1422:207-234.
73. Drews J. Drug discovery: a historical perspective. Science 2000, 287:1960-1963.
74. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007, 25:787-820.
75. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, et al. Crystal structure of the human β 2 adrenergic G-protein-coupled receptor. Nature 2007, 450:383.
76. Devoino LV, Alperina EL, Gevorgyan MM, Cheido MA. Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation. Neurosci Behav Physiol 2007, 37:147-151.
77. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, et al. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in ratsmonitored by immunohistochemistry and PET imaging. Eur J Neurosci 2002, 15:991-998.
78. Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, et al. The role of glial cells in Parkinson's disease. Curr Opin Neurol 2001, 14:483-489.
79. Guyon A, Nahon JL. Multiple actions of the chemokine stromal cell-derived factor-1α on neuronal activity. J Mol Endocrinol 2007, 38:365-376.
80. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-59.
81. Devi LA. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci 2001, 22:532-537.
82. Milligan G. High-content assays for ligand regulation of G-protein-coupled receptors. Drug Discov Today 2003, 8:579-585.
83. Milligan G, White JH. Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol Sci 2001, 22:513-518.
84. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, et al. Direct protein-protein coupling enables crosstalk between dopamine D5 and γ-aminobutyric acid A receptors. Nature 2000, 403:274-280.
85. Gilchrist A.Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci 2007, 28:431-437.
86. Baker JG, Hill SJ. Multiple GPCR conformations and signalling pathways: implication for antagonist affinity estimates. Trends Pharmacol Sci 2007, 28:375-381.
87. Baneres JL, Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B-4 receptor BLT1 and the G-protein. J Mol Biol 2003, 329:815-829.
88. Pin JP, Kniazeff J, Liu J, Binet V, Goudet C, et al. Allosteric functioning of dimeric class C G-proteincoupled receptors. FEBS Lett 2005, 272:2947-2955.
89. Damian M, Martin A, Mesnier D, Pin JP, Banéres JL. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J 2006, 25:5693-5702.
90. White JF, Grodnitzky J, Louis JM, Trinh LB, Shiloach J, et al. Dimerization of the class A G proteincoupled neurotensin receptor NTS1 alters G protein interaction. Proc Natl Acad Sci USA 2007, 104:12199-12204.
91. Whorton MR, Bokoch MP, Rasmussen SGF, Huang B, Zare RN, et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci USA 2007, 104:7682-7687.
92. Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem 2007, 282:14875-14881.
93. Bayburt TH, Grinkova YV, Sligar SG. Self-assembly of discoidal phospholipid bilayer nanoparticles with membrane scaffold proteins. Nano Lett 2002, 2:853-856.
94. Briddon SJ, Hill S. Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes. Trends Pharmacol Sci 2007, 28:637-645.
95. Service RF. Can sensors make a home in the body? Science 2002, 297:962-963.
96. Cui D, Tian F, Ozkan CS, Wang M, Gao H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005, 155:73-85.
97. Zhang D, Yi C, Zhang J, Chen Y, Yao X, et al. The effects of carbon nanotubes on the proliferation and differentiation of primary osteoblasts. Nanotechnology 2007, 18:475102.
98. Cavalcanti A, Shirinzadeh B, Freitas RA Jr, Hogg T. Nanorobot architecture for medical target identification. Nanotechnology 2008, 19:0151013.
99. Kim YI, Park TS, Kang JH, Lee MC, Kim JT, et al. Biosensors for label free detection based on RF and MEMS technology. Sens Actuators, A 2006, 119:592-599.
100. Artyukhin AB, Shestakov A, Harper J, Bakajin O, Stroeve P, et al. Functional one-dimensional lipid bilayers on carbon nanotube templates. J Am Chem Soc 2005, 127:7538-7542.
101. Schrlau MG, Falls EM, Ziober BL, Bau HH. Carbon nanopipettes for cell probes and intracellular injection. Nanotechnology 2008, 19:015101.
102. Editorial. Nat Nanotechnol 2007, 2:451.